Cisplatin is one of the most commonly used anticancer drugs worldwide. It is mainly used in
the treatment of ovarian cancer, but also used in testicular, bladder and lung cancers. The …

Advanced stages of cancer are highly associated with short overall survival in patients due
to the lack of long-term treatment options following the standard form of care. New options …

Cancer represents one of the most pernicious public health problems with a high mortality
rate among patients worldwide. Chemotherapy is one of the major therapeutic approaches …

Cisplatin (CDDP), carboplatin (CP), and oxaliplatin (OXP) are three platinating agents
clinically approved worldwide for use against a variety of cancers. They are canonically …

Autophagy, usually referred to as macroautophagy, is a cytoprotective behavior that helps
cells, especially cancer cells, escape crises. However, the role of autophagy in cancer …

Serous ovarian carcinoma (SOC) is a gynecological malignancy with high mortality rates.
Currently, there is a lack of reliable biomarkers for accurate SOC patient prognosis. Here, we …

Simple Summary The transformation and mechanism of methionine metabolism of renal cell
carcinoma (RCC) under a hypoxic microenvironment is not well understood as yet. This …

Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors
worldwide, and its prognosis is still not optimistic. Oxaliplatin is a type of platinum …

Enhancer of zeste homolog 2 (EZH2), which is overexpressed in a wide range of tumors,
contributes to ovarian cancer malignancy in several different ways. We aimed to illustrate the …

Chemotherapy resistance is a bottleneck for ovarian cancer treatment; therefore, revealing
its regulatory mechanism is critical. In the present study, we found that prostate tumor …